Replies to post #3108 on The Valens Company Inc. (VLNS)

[GE_Jim]

The sept outlook from their website would be perhaps the best. I don't think will come out so good on this screen but I'll print it any way along with the website link
https://thevalenscompany.com/investors/

CAPITALIZATION TABLE
(In CAD$MM, Unless otherwise noted)
Share Price as of August 31, 2020 $2.28
Basic Shares O/S as of July 15, 2020 128.0
Full Diluted Shares O/S as of July 15, 2020 132.0
As of May 31, 2020:
Equity Value 300.9
Cash and Cash Equivalents 45.1
ITM Securities 5.9
Debt 20.0
Enterprise Value 269.9
Average Analyst Estimates* 2019 2020 2021 2022
Revenue 58.1 91.7 149.6 202.0
Adjusted EBITDA 27.4 21.0 41.1 57.3
EPS -$0.06 -$0.04 $0.07 $0.18
Implied Multiples* 2019 2020 2021 2022
Valens EV/EBITDA 9.8x 13.0x 6.6x 4.7x
Pharma CMO Average EV/EBITDA* 20.0x 15.1x 13.8x 12.8x
Packaged Foods CMO Average EV/EBITDA* 12.0x 15.0x 11.7x 8.9x
Canadian Cannabis Peer Average EV/EBITDA* nmf 28.4x 21.7x 13.2x
Valens P/E nmf nmf 31.7x 12.5x
Pharma CMO Average P/E* 29.9x 26.9x 23.3x 20.3x
Packaged Foods CMO Average P/E* 11.3x 17.9x 22.0x 15.1x
Canadian Cannabis Peer Average P/E* nmf 70.2x 23.1x 42.4x
Analyst Target Price*
Average (9 Analysts) $4.84
Implied Return Potential 112%